NCT02267213 2019-02-26
Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma
Taiwan Liposome Company
Phase 2 Terminated
Clinical Trials
3 trialsNCT03035006 2018-11-06
Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
Taiwan Liposome Company
Phase 1/2 Terminated
NCT01425996 2018-08-21
A Dose-escalation Study of LipotecanĀ® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
Taiwan Liposome Company
Phase 1/2 Terminated